APOTHEEK NOORDERLAAN
De berekende faillissementskans van APOTHEEK NOORDERLAAN over 12 maanden bedraagt 0,6% (laag). Het bedrijf is actief sinds 2007 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 18 jaar |
| Vestigingen | 1 |
| Publicaties | 2 |
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-03-2025 | verkort | 24-09-2025 | 2025-00500611 |
| 31-03-2024 | verkort | 30-10-2024 | 2024-00519125 |
| 30-06-2022 | verkort | 30-11-2022 | 2022-20530337 |
| 30-06-2021 | verkort | 03-12-2021 | 2021-79100563 |
| 30-06-2020 | verkort | 01-12-2020 | 2020-74000532 |
| 30-06-2019 | verkort | 19-12-2019 | 2019-76500211 |
| 30-06-2018 | verkort | 23-01-2019 | 2019-01900389 |
| 30-06-2017 | verkort | 15-01-2018 | 2018-01100296 |
| 30-06-2016 | verkort | 28-02-2017 | 2017-05400063 |
| 30-06-2015 | verkort | 29-01-2016 | 2016-03300247 |
| NACE primair | Detailhandel(47730) |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 18-12-2007 |
| Status | Actief |
| Postcode | 2030 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 11807G2179/00E003 | Vlaanderen | 1.452 m² | 1 · 1.224 m² | 7,0 m · 2 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
21-11-2024 Alle aandelen zijn voortaan in handen van één aandeelhouder
Technische details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "EY Bedrijfsrevisoren",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
}
],
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "vzw_capital_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Willem Muyshondt",
"firm_city": null,
"firm_name": null,
"office_city": "Halle",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-11-21",
"filing_date": "2024-11-19",
"act_kind_objet": "WIJZIGING RECHTSVORM, KAPITAAL, AANDELEN, STATUTEN"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-06-28",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2024-06-26"
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "EY Bedrijfsrevisoren",
"ibr_number": null,
"mission_type": "quasi_apport",
"individual_name": "Emilie VAN CALLEMONT"
},
"subject_company": {
"kbo": "0894.785.309",
"name_full": "APOTHEEK NOORDERLAAN",
"legal_form": "Besloten Vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": []
}20-11-2024 3 bestuurders benoemd
- EY Bedrijfsrevisoren, Commissaris
- Mathias AERTSEN, Dagelijks bestuur
- Juna JACQUEMIN, Dagelijks bestuur
Technische details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "EY Bedrijfsrevisoren",
"address": "Kouterveldstraat 7B Bus 001, 1831 Diegem",
"country": "BE",
"legal_form": "BV"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "De enige Aandeelhouder besluit te benoemen als commissaris van de Vennootschap, met ingang van het boekjaar eindigend op 31 maart 2025, de besloten vennootschap \u0022EY Bedrijfsrevisoren\u0022",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2026"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": null,
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Mathias AERTSEN",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering verleent, voor zoveel als nodig, bijzondere volmacht aan de heer Mathias AERTSEN en mevrouw Juna JACQUEMIN, en iedere andere medewerker van de Vennootschap of een daarmee verbonden vennootschap in de zin van artikel 1:20 WVV, om, individueel bevoegd en met recht van indeplaatsstelling",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Juna JACQUEMIN",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering verleent, voor zoveel als nodig, bijzondere volmacht aan de heer Mathias AERTSEN en mevrouw Juna JACQUEMIN, en iedere andere medewerker van de Vennootschap of een daarmee verbonden vennootschap in de zin van artikel 1:20 WVV, om, individueel bevoegd en met recht van indeplaatsstelling",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-11-20",
"filing_date": "2024-11-05",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2024-06-26",
"unanimous": true
},
{
"body": "bijzondere_algemene_vergadering",
"date": "2024-06-26",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0894.785.309",
"name_full": "Apotheek Noorderlaan",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Mathias Aertsen",
"org_rep_person_name": null,
"person_role_at_subject": "lasthebber"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamNL | APOTHEEK NOORDERLAAN |